VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,268,512 | -60.5% | 455,551 | +3.4% | 0.00% | -66.7% |
Q2 2023 | $10,810,788 | -6.2% | 440,717 | -11.0% | 0.00% | 0.0% |
Q1 2023 | $11,525,818 | -8.2% | 495,308 | -0.2% | 0.00% | -25.0% |
Q4 2022 | $12,559,479 | +28.7% | 496,226 | -1.9% | 0.00% | +33.3% |
Q3 2022 | $9,755,000 | -21.1% | 505,946 | +4.2% | 0.00% | -25.0% |
Q2 2022 | $12,370,000 | +1096.3% | 485,660 | +1108.5% | 0.00% | – |
Q1 2022 | $1,034,000 | -86.5% | 40,188 | -78.1% | 0.00% | -100.0% |
Q4 2021 | $7,671,000 | +403.3% | 183,201 | +423.3% | 0.00% | – |
Q3 2021 | $1,524,000 | +3.0% | 35,008 | +11.9% | 0.00% | – |
Q2 2021 | $1,479,000 | +65.8% | 31,290 | +79.8% | 0.00% | – |
Q1 2021 | $892,000 | +191.5% | 17,398 | +52.1% | 0.00% | – |
Q4 2020 | $306,000 | -68.6% | 11,438 | -51.9% | 0.00% | – |
Q2 2020 | $975,000 | – | 23,804 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |